Safety Study of Adenovirus Hepatocyte Growth Factor to Treat Ischemic Heart Disease
Clinical trial NCT01925352 · UNKNOWN
Trial details
- NCT number
- NCT01925352
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2015-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.